Valuing Bio-Rad using a discounted cash flow model indicates that the BIO stock is overvalued by 20.10%. I do not consider Bio-Rad Laboratories (NYSE:BIO) to be a good investment opportunity. Between ...

Shares of SpaceX competitor Rocket Lab USA climbed to a record high Monday after the company announced two successful ...

Shares of Rocket Lab USA, Inc. (NASDAQ:RKLB) jumped over 11% in pre-market trading on Monday after it received a $23.9 ...

Shares of Rocket Lab USA Inc. are up 11.5% in premarket trading after completing successful launches in two different hemispheres in less than 24 hours. At 10:55 p.m. Eastern time Sunday, Rocket Lab’s ...

Shares of Rocket Lab USA Inc. are up 7.2% in premarket trades, boosted by successful launches in two different hemispheres in ...